Insider Trading - Day One Biopharmaceuticals Inc. (DAWN)
Real time insider trading transaction history:
- Insiders must file a Form 4 covering their trades within two business days.
- Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-01 Purchase | 2021-06-01 9:50 pm | Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director | 5,000 | $16 | $80,000 | 68,000 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-01 9:51 pm | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 7,000 | $16 | $112,000 | 136,473 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-02 5:12 pm | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 13,000 | $16 | $208,000 | 10,735,645 (Direct) | View |
| 2021-02-01 Purchase | 2021-06-02 6:40 pm | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner | 500,000 | $16 | $8,000,000 | 991,396 (Indirect) | View |
| 2021-02-01 Purchase | 2021-06-02 8:52 pm | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 13,000 | $16 | $208,000 | 11,411,924 (Indirect Direct) | View |
| 2021-06-01 Purchase | 2021-06-03 4:42 pm | Day One Biopharmaceuticals Inc. | DAWN | AI Day 1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 875,000 | $16 | $14,000,000 | 9,377,776 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 7:19 pm | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 10,000 | $17.22 | $172,242 | 2,376,718 (Indirect Direct) | View |
| 2021-12-03 Sale | 2021-12-07 06:01 am | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 110,209 | $18.1 | $1,994,530 | 6,417,397 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-06-01 Option Award | 2021-06-01 9:50 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Becker Daniel J. Director | 63,000 | $0 | 68,000 (Direct) | View |
| 2021-06-01 Option Award | 2021-06-01 9:51 pm | N/A 2031-05-25 | Day One Biopharmaceuticals Inc. | DAWN | Josey John A. Director | 64,181 | $0 | 136,473 (Direct) | View |
| 2021-06-01 Conversion | 2021-06-02 5:12 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner | 7,476,776 | $0 | 10,735,645 (Direct) | View |
| 2021-02-01 Conversion | 2021-06-02 6:40 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. Atlas Venture Associates Opportunity I LLC Atlas Venture Opportunity Fund I L.P. Atlas Venture Associates Opportunity I L.P. Atlas Venture Associates XI L.P. Atlas Venture Associates XI LLC 10% Owner | 8,502,776 | $0 | 991,396 (Indirect) | View |
| 2021-02-01 Option Award | 2021-06-02 8:52 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 211,279 | $0 | 11,411,924 (Indirect) | View |
| 2021-02-01 Conversion | 2021-06-02 8:52 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director | 7,476,776 | $0 | 11,411,924 (Indirect) | View |
| 2021-06-01 Conversion | 2021-06-03 4:42 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | AI Day 1 LLC Access Industries Holdings LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner | 17,005,552 | $0 | 9,377,776 (Direct) | View |
| 2021-08-16 Option Award | 2021-08-18 7:03 pm | N/A 2031-08-15 | Day One Biopharmaceuticals Inc. | DAWN | Garland J. Scott Director | 48,072 | $0 | 48,072 (Direct) | View |
| 2021-11-24 Other | 2021-11-29 5:16 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 57,224 | $0 | 6,584,830 (Indirect) | View |
| 2021-11-24 Other | 2021-11-29 5:30 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner | 801,138 | $0 | 8,011,380 (Direct) | View |
| 2021-12-01 Gift | 2021-12-03 7:19 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer | 1,000,000 | $0 | 2,376,718 (Direct) | View |